Bupivacaine hydrochloride monohydrate

CAS No. 73360-54-0

Bupivacaine hydrochloride monohydrate( —— )

Catalog No. M37272 CAS No. 73360-54-0

Bupivacaine hydrochloride monohydrate is a potent NMDA receptor inhibitor of sodium, L-calcium, and potassium channels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG 3537 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bupivacaine hydrochloride monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bupivacaine hydrochloride monohydrate is a potent NMDA receptor inhibitor of sodium, L-calcium, and potassium channels.
  • Description
    Bupivacaine hydrochloride monohydrate is a NMDA receptor inhibitor. Bupivacaine hydrochloride monohydrate can block sodium, L-calcium, and potassium channels. Bupivacaine hydrochloride monohydrate potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride monohydrate can be used for the research of chronic pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel | Potassium Channel | Calcium Channel | NMDAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    73360-54-0
  • Formula Weight
    342.9
  • Molecular Formula
    C18H31ClN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.O=C(NC=1C(=CC=CC1C)C)C2N(CCCC)CCCC2.O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Meaghan A Paganelli, et al. Actions of Bupivacaine, a widely used local anesthetic, on NMDA receptor responses. J Neurosci. 2015 Jan 14;35(2):831-42.?
molnova catalog
related products
  • Tocainide

    Tocainide is a blocker of the sodium channel and used for the treatment of tinnitus.

  • Nav1.7 inhibitor

    Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.

  • Lacosamide

    An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.